ArticleJPRAS open2025
Epstein Barr Virus (EBV) positive large B-cell lymphoma associated with breast implants: A case report.
Article in JPRAS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast lymphoma associated with implants is an uncommon condition, with B-cell lymphomas representing a small subset. Among these, diffuse large B-cell lymphoma (DLBCL), particularly Epstein-Barr Virus (EBV)-positive, is extremely rare and poorly characterized. This lymphoma subtype differs from the more prevalent implant-associated anaplastic large-cell lymphoma. Chronic inflammation caused by prolonged contact between the implant and surrounding tissues is believed to create a microenvironment favorable for lymphoid proliferation and malignancy, though the underlying mechanisms remain speculative and require further exploration. We report the case of a female patient with Poland syndrome, a congenital anomaly involving chest wall deformities, who underwent left-sided breast reconstruction with an implant. She presented with implant rupture and capsular contracture, necessitating surgical removal of the implant and surrounding capsule. A total capsulectomy was performed, and reconstruction utilized the "no-touch" technique to reduce contamination. Intraoperative abnormalities of the periprosthetic capsule led to its submission for pathological analysis. Histopathological and immunohistochemical studies confirmed EBV-positive DLBCL. A PET/CT scan showed no hypermetabolic activity or extramammary involvement. Multidisciplinary evaluation concluded that conservative management with regular follow-up was appropriate, given the favorable prognosis. The patient remains under observation with no signs of recurrence. This case highlights the importance of considering lymphoma in patients with implants presenting with capsular changes or unexplained symptoms. Early diagnosis, involving thorough histopathological analysis and advanced imaging, is critical to guide management. Although EBV-positive implant-associated B-cell lymphomas generally have a good prognosis and rarely require aggressive treatment, their rarity underscores the need for continued documentation and research. Expanding our understanding of their pathogenesis and clinical behavior will help refine diagnostic and therapeutic approaches, improving patient outcomes. Section category: Reconstructive.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.